Publicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas (17)

2023

  1. DNA Methylation Description of Hippocampus, Cortex, Amygdala, and Blood of Drug-Resistant Temporal Lobe Epilepsy

    Molecular Neurobiology, Vol. 60, Núm. 4, pp. 2070-2085

2022

  1. CNVs Associated with Different Clinical Phenotypes of Psoriasis and Anti-TNF-Induced Palmoplantar Pustulosis

    Journal of Personalized Medicine, Vol. 12, Núm. 9

  2. Pharmacogenetics of Donepezil and Memantine in Healthy Subjects

    Journal of Personalized Medicine, Vol. 12, Núm. 5

2021

  1. ABCB1 C3435T, G2677T/A and C1236T variants have no effect in eslicarbazepine pharmacokinetics

    Biomedicine and Pharmacotherapy, Vol. 142

  2. Epigenetics in Non-tumor Immune-Mediated Skin Diseases

    Molecular Diagnosis and Therapy, Vol. 25, Núm. 2, pp. 137-161

  3. Growth arrest and DNA damage-inducible proteins (GADD45) in psoriasis

    Scientific Reports, Vol. 11, Núm. 1

  4. Methylation in psoriasis. Does sex matter?

    Journal of the European Academy of Dermatology and Venereology

2020

  1. Genome-wide association analysis of psoriasis patients treated with anti-TNF drugs

    Experimental Dermatology, Vol. 29, Núm. 12, pp. 1225-1232

  2. Polymorphisms associated with optimization of biological therapy through drug dose reduction in moderate-to-severe psoriasis

    Journal of the European Academy of Dermatology and Venereology

2019

  1. Polymorphisms associated with anti-TNF drugs response in patients with psoriasis and psoriatic arthritis

    Journal of the European Academy of Dermatology and Venereology

2018

  1. Effect of Polymorphisms on the Pharmacokinetics, Pharmacodynamics and Safety of Sertraline in Healthy Volunteers

    Basic and Clinical Pharmacology and Toxicology, Vol. 122, Núm. 5, pp. 501-511

  2. Epigenetic biomarkers associated with antitumour necrosis factor drug response in moderate-to-severe psoriasis

    British Journal of Dermatology

  3. Histone modifications associated with biological drug response in moderate-to-severe psoriasis

    Experimental Dermatology, Vol. 27, Núm. 12, pp. 1361-1371

  4. How to make P-glycoprotein (ABCB1, MDR1) harbor mutations and measure its expression and activity in cell cultures?

    Pharmacogenomics, Vol. 19, Núm. 16, pp. 1285-1297

  5. Polymorphisms associated with adalimumab and infliximab response in moderate-to-severe plaque psoriasis

    Pharmacogenomics, Vol. 19, Núm. 1, pp. 7-16

2017

  1. Pharmacogenetics of trazodone in healthy volunteers: Association with pharmacokinetics, pharmacodynamics and safety

    Pharmacogenomics, Vol. 18, Núm. 16, pp. 1491-1502

  2. Polymorphisms associated with etanercept response in moderate-to-severe plaque psoriasis

    Pharmacogenomics, Vol. 18, Núm. 7, pp. 631-638